| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kiora Pharmaceuticals Inc (KPRX) has 0 insiders with recent SEC Form 4 filings, including 31 buys and 0 sells. KPRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 26, 2018 | Armistice Capital, LLC56 | 10% Owner | Buy | 165,522 | $0.54 | $89,266.30 | +0.2% | |
| Apr 20, 2018 | Armistice Capital, LLC56 | 10% Owner | Buy | 2,534,478 | $0.49 | $1,231,158.70 | +1.9% | |
| Apr 17, 2018 | Garanzini Michael | Chief Commercial Officer | Buy | 156,250 | $0.00 | - | +1,042% | |
| Apr 17, 2018 | From Stephen | President And CEO | Buy | 125,000 | $0.00 | - | +43.9% | |
| Apr 17, 2018 | Romano Sarah81 | Chief Financial Officer | Buy | 62,500 | $0.00 | - | +140.9% | |
| Apr 17, 2018 | Armistice Capital, LLC56 | 10% Owner | Buy | 10,479,970 | $0.36 | $3,740,050.05 | +10.7% | |
| Aug 15, 2017 | Romano Sarah81 | Interim CFO | Buy | 10,000 | $1.00 | $10,000.00 | +44.4% | |
| Aug 10, 2017 | From Stephen | President And CEO | Buy | 12,500 | $1.03 | $12,875.00 | +4.8% | |
| Jun 14, 2017 | Romano Sarah81 | Interim CFO | Buy | 20,000 | $0.00 | - | +800.0% | |
| Jun 14, 2017 | From Stephen | President And CEO | Buy | 60,000 | $0.00 | - | +30.0% |